Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Evi Vakiani"'
Autor:
Jose Jimenez, Adam T. Boutin, Roel G.W. Verhaak, Levi A. Garraway, Yuji Mishina, Alex H. Ramos, Trevor J. Pugh, Adam J. Bass, Nicolas Stransky, Kristian Cibulskis, Ronald A. DePinho, William G. Kaelin, Yotam Drier, Gad Getz, Matthew Meyerson, Wenlin Shao, Shuji Ogino, Yujin Hoshida, Gordon Saksena, Sabina Signoretti, Andrey Sivachenko, William C. Hahn, Jose Baselga, Rui Jing, Lynda Chin, Derek Y. Chiang, Carrie Sougnez, Lear E. Brace, Michael S. Lawrence, Evi Vakiani, Douglas Voet, Josep Tabernero, Melissa Parkin, Stacey Gabriel, David B. Solit, Nicole Spardy, Jordi Barretina, Markus Warmuth, Charles S. Fuchs, Eric S. Lander
Publikováno v:
PMC
Prior studies have identified recurrent oncogenic mutations in colorectal adenocarcinoma1 and have surveyed exons of protein-coding genes for mutations in 11 affected individuals2,3. Here we report whole-genome sequencing from nine individuals with c
Autor:
Anna M. Varghese, J.F. Hechtman, Nikolaus Schultz, Neil H. Segal, L. B. Saltz, David M. Hyman, J. Garcia Aguilar, Evi Vakiani, Jinru Shia, Andrea Cercek, Walid K. Chatila, Luis A. Diaz, G. Dos Santos Fernandes, Diane Lauren Reidy, M.F. Berger, Zsofia K. Stadler, Robin B. Mendelsohn, Rona Yaeger, David B. Solit
Publikováno v:
Annals of Oncology. 29:viii197
Autor:
Philip Jonsson, Yaelle Tuvy, Evi Vakiani, Laura H. Tang, David P. Kelsen, David B. Solit, D. Ilson, Margaret K. Callahan, Geoffrey Y. Ku, Jamie Riches, Nancy Bouvier, J.F. Hechtman, M.F. Berger, Nikolaus Schultz, Francisco Sanchez-Vega, Zsofia K. Stadler, Ritika Kundra, Yelena Y. Janjigian, Barry S. Taylor
Publikováno v:
Annals of Oncology. 27:vi208
Autor:
Roberta Schiavo, Andrea Cercek, Valentina Boscaro, F. Di Nicolantonio, Silvio Veronese, Sebastijan Hobor, Margherita Gallicchio, Martin R. Weiser, Enzo Medico, Evi Vakiani, Elisa Scala, Katia Bencardino, Emanuele Valtorta, Marcello Gambacorta, Rona Yaeger, Chin-Tung Chen, Carlo Zanon, Alberto Bardelli, Andrea Sartore-Bianchi, Michela Buscarino, G. Siravergna, Sandra Misale, S. Siena, David Liska, Manickam Janakiraman, David B. Solit
Publikováno v:
Annals of Oncology. 23:v24
A main limitation of therapies that selectively target kinase signaling pathways is the emergence of secondary drug resistance. Cetuximab, a monoclonal antibody that binds the extracellular domain of EGFR, is effective in a subset of KRAS wild type m
Publikováno v:
Transplant Research and Risk Management. :1
Brock Macdonald1 Evi Vakiani2 Rhonda K Yantiss3 Jun Lee4 Robert S Brown Jr5 Samuel H Sigal6 1Division of Gastroenterology, Department of Medicine, University of California-San Francisco, San Francisco, CA, 2Department of Pathology, Memorial Sloan–K
Publikováno v:
American Journal of Gastroenterology. 103:S157
Autor:
Jeremy P.C. Steele, Jonathan Shamash, Robin M. Rudd, N.H. Gower, Evi Vakiani, Claire Barlow, Dean A. Fennell, M.T. Evans, Michael Sheaff, Paula Wells
Publikováno v:
Lung Cancer. 41:S221
Autor:
Evi Vakiani, Michael Sheaff, Jeremy P.C. Steele, Robin M. Rudd, M.T. Evans, N.H. Gower, Claire Barlow, Dean A. Fennell, Paula Wells, Jonathan Shamash
Publikováno v:
Lung Cancer. 41:S221